Announcements Trials
Browse Landscape

Phase

Phase 4 5Phase 2 3Phase 3 2Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1Phase 1/2 1

Status

Completed 9Recruiting 8Terminated 7Unknown 3Not yet recruiting 2Active not recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Stomach Neoplasms 1Pancreatic Neoplasms 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Propranolol × Clear all
NCT04493489 2020-07-30

Propranolol Adjuvant Treatment of Bladder Cancer

Central South University

Phase 2 Unknown
242 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT04005365 2019-11-26

Clinical Study of Propranolol Combined With Neoadjuvant Chemotherapy in Gastric Cancer

Central South University

Phase 2 Unknown
78 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03838029 2019-11-20

BC-PC

Assaf-Harofeh Medical Center

Phase 2 Unknown
210 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡